Superworth

Diagnostics and research stocks with the fastest earnings growth

Earnings per share over the last twelve months against the twelve months before, for companies profitable in both. As of .

Ranked
17
of 74 diagnostics and research stocks we cover
Median
+12.5%
Highest
+100.8%
CDNA
Range
−67.1% to +100.8%
median +12.5%
−67.1%+100.8%
#CompanyEPS growthPERevenue growth (TTM)Market cap
1CDNACareDx+100.8%35.9×+38.9%$4.5B
2LHLabcorp+33.3%29.4×+6.4%$28.9B
3MEDPMedpace+26.8%38.0×+24.7%$18.1B
4DHRDanaher+26.0%37.9×+5.5%$162.6B
5AAgilent Technologies+19.2%34.5×+8.6%$49.6B
6IDXXIDEXX Laboratories+18.4%46.5×+12.8%$52.1B
7DGXQuest Diagnostics+18.3%24.9×+9.1%$27.5B
8IQVIQVIA+16.6%32.0×+8.2%$42.5B
9MTDMettler-Toledo International+12.5%38.4×+6.9%$34.2B
10LNTHLantheus+9.8%24.3×+2.3%$6.5B
11TMOThermo Fisher Scientific+9.5%36.7×+8.3%$256.9B
12RVTYRevvity−11.0%72.2×+4.1%$16.9B
13BIOBio-Rad Laboratories−29.7%44.4×+1.4%$9.8B
14ILMNIllumina−32.0%44.0×+4.9%$35.7B
15ICCCImmucell−57.9%132×+8.5%$95.9M
16WATWaters−63.8%118×+52.5%$46.4B
17NRCNRC Health−67.1%97.0×−0.2%$536.6M

Not ranked: 48 with not a meaningful number, 4 with no profit to compare, 1 with a quarter missing, 1 with growth above 300% (a base too small to compare). 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

EPS growth for other groups

Other rankings of diagnostics and research stocks

The group